Join
today

Boliven PRO is more than just Clinical Trials

  • Search for throughout all clinical trials
  • Analyze data with charts and graphs, then download your results
  • Share lists of patents with your clients

Search trademarks, companies, patents & more!

Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester


Trial Overview

StatusConditionSponsor/Collaborator(s)First ReceivedLast ChangedVerification Date
Completed Down Syndrome University Hospital, Strasbourg, France Other September 13, 2005 May 13, 2011 May 2011

Study TypeStudy DesignPhaseEnrollmentStart DateEnd Date
Observational Observational Model: Case-Only, Time Perspective: Prospective N/A 20000 July 2003 -

Locations

FacilityAddressContactPhoneEmailStatus
Département de Gynécologie-Obstétrique, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg Strasbourg Alsace 67098 France - - - -
Service de Gynécologie-Obstétrique, SIHCUS, CMCO Strasbourg Alsace 67303 France - - - -
Centre Hospitalier Belfort 90000 France - - - -
Centre Mère et Enfant LE PARC, Service de Gynécologie Obstétrique Colmar 68024 France - - - -
Centre de Périnatalité, Hôpital Civil Guebwiller 68500 France - - - -
Centre Hospitalier du Hasenrain Mulhouse 68051 France - - - -
Clinique ADASSA Strasbourg 67000 France - - - -

Intervention

TypeInterventionDescription
Device echography -
Other blood sample -

Official Title

Nuchal Translucency Study - PAPP-A

Eligibility

GenderMinimum AgeMaximum AgeHealthy Volunteers
Female - N/A Accepts Healthy Volunteers

Inclusion Criteria:

- Female > 18 years old

- Pregnant

Exclusion Criteria:

- Maternal age < 18 years old, twin pregnancy